首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2020年 6期“非酒精性脂肪性肝病与多代谢紊乱的基础与临床” => 病毒性肝炎 =>HBV相关慢加急性肝..
HBV相关慢加急性肝衰竭患者糖皮质激素受体表达特征及其与疗效的关系
Expression features of glucocorticoid receptor and its association with treatment outcome in patients with hepatitis B virus-related acute-on-chronic liver failure
文章发布日期:2020年06月01日  来源:  作者:董金玲,贾琳,杨君,等  点击次数:195次  下载次数:44次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的 探讨糖皮质激素(GC)治疗早期和中期HBV相关慢加急性(亚急性)肝衰竭(HBV-ACLF)患者时激素受体(GR)及其亚型α、β的表达特征与激素治疗敏感性的关系。方法 采用前瞻性、非随机对照研究方法入组2015年9月-2018年6月北京佑安医院住院治疗的33例早、中期HBV-ACLF患者,其中激素组18例在内科综合治疗基础上给予甲基强的松龙静点7 d。采用流式细胞检测仪和逆转录PCR(RT-PCR)检测GR及GR-α mRNA、GR-β mRNA表达情况,观察基线、8 d GR及其亚型表达差异。激素组患者根据10 d时GC疗效分为激素敏感组(13例)和激素不敏感组(5例),分析不同组别GR及其亚型表达的特征与GC治疗敏感性的关系。计量资料2组间比较采用两独立样本t检验,自身前后对照比较采用配对t检验;计数资料2组间比较采用确切概率法检验。28 d生存情况采用Kaplan- Meier生存曲线进行分析,2组间比较采用log-rank检验。结果 激素组患者使用激素后8 d时GR-α mRNA表达水平[(0.99±0.48)×10-2)]较基线[(1.96±0.50)×10-2)]明显降低(t=6.586,P<0.001)。激素组与非激素组患者第8 d时GR-α mRNA表达[(0.99±0.48)×10-2vs (1.70±0.66)×10-2]差异有统计学意义(t=-3.518,P=0.001);激素敏感与不敏感组8 d时比较,激素敏感组GR-α mRNA表达水平[(1.21±0.34)×10-2]明显高于激素不敏感组[(0.43±0.31)×10-2](t=4.456,P<0.001);且8 d时激素敏感组GR-α mRNA表达降低幅度明显小于激素不敏感组(t=-2.904,P=0.01)。GR-β mRNA表达水平8 d时激素敏感组[(0.14±0.08)×10-2]与激素不敏感组[(0.10±0.04)×10-2]差异无统计学意义(t=1.092,P=0.291)。8 d时激素组患者GR-α mRNA表达降低幅度与基线的比值均值为46%,据此分为≤46%组(10例)和>46%组(8例)。2组GR-α mRNA表达水平降低幅度与基线的比值差异显著(26.99%±25.09% vs 70.09%±16.08%,t=-4.203,P=0.001)。10 d时,TBil降低幅度与基线比值在≤46%组和>46%组间差异显著(P=0.021);10 d时,PTA上升幅度与基线比值在≤46%组和>46%组间差异显著(P=0.048)。结论 HBV-ACLF早、中期患者使用GC后GR-α mRNA表达水平明显降低,激素敏感组患者GR-α mRNA水平较基线降低幅度小,且28 d TBil和PTA指标改善优于激素不敏感组,GR-α mRNA动态变化对激素疗效具有一定参考价值。
【Abstract】:Objective To investigate the expression features of glucocorticoid receptor (GR) and its subtypes α and β in patients with early- or middle-stage hepatitis B virus-related acute/subacute-on-chronic liver failure (HBV-ACLF) treated by glucocorticoid (GC) and their association with sensitivity to glucocorticoid therapy. Methods A prospective non-randomized controlled trial was performed for 33 patients with early- or middle-stage HBV-ACLF who were hospitalized and treated in Beijing YouAn Hospital from September 2015 to June 2018, and among these patients, 18 received intravenous infusion of methylprednisolone for 7 days in addition to comprehensive medical treatment. Flow cytometry and RT-PCR were used to measure the mRNA expression of GR, GR-α, and GR-β, and the expression of GR, GR-α, and GR-β was observed at baseline and on day 8. According to the response to GC on day 10, the hormone group was further divided into hormone-sensitive group with 13 patients and hormone-insensitive group with 5 patients. The two-independent-samples t test was used for comparison of continuous data between two groups, and the paired t-test was used for comparison within one group before and after treatment; the Fisher’s exact test was used for comparison of categorical data between groups. The Kaplan-Meier survival curve was used to analyze 28-day survival, and the log-rank test was used for comparison between groups. Results The hormone group had a significant reduction in the mRNA expression of GR-α on day 8 after hormone administration [(0.99±0.48)×10-2 vs (1.96±0.50)×10-2, t=6.586, P<0.001]There was a significant difference in the mRNA expression of GR-α between the hormone group and the non-hormone group on day 8 [0.99±0.48)×10-2 vs (1.70±0.66)×10-2, t=-3.518, P=0.001]On day 8, the hormone-sensitive group had significantly higher mRNA expression of GR-α than the hormone-insensitive group [1.21±0.34)×10-2 vs (0.43±0.31)×10-2, t=4.456, P<0.001]and the hormone-sensitive group had a significantly greater reduction in the mRNA expression of GR-α compared with the hormone-insensitive group (t=-2.904, P=0.01). There was no significant difference in the mRNA expression of GR-β on day 8 between the hormone-sensitive group and the hormone-insensitive group [0.14±0.08)×10-2 vs (0.10±0.04)×10-2, t=1.092, P=0.291]For the hormone group, the mean ratio of reduction in GR-α mRNA expression to baseline value was 46% on day 8, and according to this, the patients were divided into ≤46% group with 10 patients and >46% group with 8 patients. There was a significant difference in the ratio of reduction in GR-α mRNA expression to baseline value between the two groups (26.99%±25.09% vs 70.09%±16.08%, t=-4.203, P=0.001). On day 10, there were significant differences between the ≤46% group and the >46% group in the ratio of reduction in total bilirubin (TBil) to baseline value (P=0.021) and the ratio of increase in prothrombin time activity (PTA) to baseline value (P=0.048). Conclusion In patients with early- or middle-stage HBV-ACLF, there is a significant reduction in the mRNA expression of GR-α after GC treatment. Patients sensitive to hormone have a relatively low degree of reduction in the mRNA expression of GR-α, with better improvements in TBil and PTA on day 28 than those insensitive to hormone. Dynamic change of GR-α mRNA has a certain reference value in predicting the outcome of hormone therapy.
【关键字】:肝功能衰竭; 乙型肝炎病毒; 糖皮质激素类; 受体,糖皮质激素
【Key words】:liver failure; hepatitis B virus; glucocorticoids; receptors,glucocorticoid
【引证本文】:DONG JL, JIA L, YANG J, et al. Expression features of glucocorticoid receptor and its association with treatment outcome in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2020, 36(6): 1252-1257. (in Chinese)
董金玲, 贾琳, 杨君, 等. HBV相关慢加急性肝衰竭患者糖皮质激素受体表达特征及其与疗效的关系[J]. 临床肝胆病杂志, 2020, 36(6): 1252-1257.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号